Trading health for wealth -- A primer on pharmaceutical IP -- Market failures and fallacies -- Local politics, strange bedfellows, and the challenges of human rights mobilization -- Patient advocacy and access to medicines litigation -- Writing globalization's rulebook

The author through this research project has focused on the fact that how systems around access to medicines has been reshaped 25 years down the line, thanks to a plethora of bilateral and multilateral agreements. On a broader level, (though not expressly stated) a comparison has been shown...

The cusp of the twentieth anniversary of the WTO Doha Declaration on the TRIPS Agreement and Public Health (hereafter "the Declaration") was marked by a global pandemic. The Declaration and its iteration in the Agreement on Trade Related Aspects of Intellectual Property Rights (hereafter...

This South Centre research paper by Dr. German Velasquez describes and analyses the mandate, programmes, strategies, and activities that different international organizations such as WHO, WTO, WIPO, UNCTAD, UNDP, UNAIDS, the UN Human Rights Council, and the UN Secretary-General's High Level...

Patent rights on pharmaceutical products are one of the factors responsible for the lack of access to affordable medicines in developing countries. In this work, Emmanuel Kolawole Oke provides a systematic analysis of the tension between patent rights and human rights law, contending that, in...